BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Arch Biopartners Inc. Announces Change in Year End


11/19/2010 11:53:03 AM

TORONTO, CANADA--(Marketwire - November 19, 2010) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX: ACH)(OTC: FOIFF) announced today that it has changed its financial year end from December 31 to September 30. This change synchronizes Arch's financial reporting with that of its four subsidiaries, which all use September 30 as financial year end.

Arch's most recent financial year ended on December 31, 2009. The change in financial year end means that the Company's next audited financial report will cover the nine month period ending September 30, 2010.

A Notice of Change in Year End will be filed today via SEDAR and will be accessible at www.sedar.com for more information about the change.

About Arch Biopartners

Arch Biopartners is a portfolio based biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies.

For more information on the Company, please consult the other public documents filed on SEDAR at www.sedar.com. The Company's website address is: www.archbiopartners.com.

The CNSX has not reviewed and does not accept responsibility for the adequacy of this release.


Contacts:
Arch Biopartners Inc.
Richard Muruve
CEO
(647) 428 7031
info@archbiopartners.com
www.archbiopartners.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES